Report Detail

Request for Sample of this report

Other Global Prenatal Testing and Newborn Screening Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4684850
    • |
  • 12 March, 2026
    • |
  • Global
    • |
  • 129 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Prenatal Testing and Newborn Screening market size was valued at US$ 6147 million in 2025 and is forecast to a readjusted size of US$ 11840 million by 2032 with a CAGR of 9.9% during review period.
Prenatal Testing and Newborn Screening refers to the integrated set of clinical and public health testing activities used to identify genetic, metabolic, and congenital conditions before birth and in the early days of life. It includes tests performed during pregnancy to assess fetal risk and guide clinical decision making, as well as systematic screening of newborns shortly after birth to enable early diagnosis, timely treatment, and long term health management.
The prenatal testing and newborn screening market represents a continuum of early life risk detection that spans preconception planning, pregnancy management, and postnatal care, giving it broader commercial scope and faster innovation cycles than postnatal screening alone. Market dynamics are shaped by the coexistence of policy driven newborn programs and more commercially flexible prenatal testing, resulting in a hybrid structure where public health governance and private clinical demand intersect. Growth is driven by expanding test adoption in routine obstetric care, advances in genetic and biochemical testing methods, and increasing integration of results into digital care pathways, while competitive differentiation centers on clinical utility, workflow integration, and alignment with regulatory and ethical frameworks across both prenatal and postnatal settings.
This report is a detailed and comprehensive analysis for global Prenatal Testing and Newborn Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prenatal Testing and Newborn Screening market size and forecasts, in consumption value ($ Million), 2021-2032
Global Prenatal Testing and Newborn Screening market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Prenatal Testing and Newborn Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Prenatal Testing and Newborn Screening market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prenatal Testing and Newborn Screening
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prenatal Testing and Newborn Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity, Quest Diagnostics, Labcorp, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Illumina, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Prenatal Testing and Newborn Screening market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Prenatal Testing
Newborn Screening
Market segment by Screening Purpose
Core Condition Screening
Expanded Condition Screening
Market segment by Service Model
Public Health Program
Consumer
Others
Market segment by Application
Public Hospitals
Private Hospitals
Others
Market segment by players, this report covers
Thermo Fisher Scientific
Revvity
Quest Diagnostics
Labcorp
MedGenome
Mayo Clinic Laboratories
GeneDx
PreventionGenetics
SYNLAB
Illumina
Cordlife
KingMed Diagnostics
BGI Genomics
Berry Genomics
Annaroad
Jiajian Medical Testing
Genesky
Weihansi Biomedical Technology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Prenatal Testing and Newborn Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prenatal Testing and Newborn Screening, with revenue, gross margin, and global market share of Prenatal Testing and Newborn Screening from 2021 to 2026.
Chapter 3, the Prenatal Testing and Newborn Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Prenatal Testing and Newborn Screening market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prenatal Testing and Newborn Screening.
Chapter 13, to describe Prenatal Testing and Newborn Screening research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Prenatal Testing and Newborn Screening by Type
    • 1.3.1 Overview: Global Prenatal Testing and Newborn Screening Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Prenatal Testing and Newborn Screening Consumption Value Market Share by Type in 2025
    • 1.3.3 Prenatal Testing
    • 1.3.4 Newborn Screening
  • 1.4 Classification of Prenatal Testing and Newborn Screening by Screening Purpose
    • 1.4.1 Overview: Global Prenatal Testing and Newborn Screening Market Size by Screening Purpose: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Prenatal Testing and Newborn Screening Consumption Value Market Share by Screening Purpose in 2025
    • 1.4.3 Core Condition Screening
    • 1.4.4 Expanded Condition Screening
  • 1.5 Classification of Prenatal Testing and Newborn Screening by Service Model
    • 1.5.1 Overview: Global Prenatal Testing and Newborn Screening Market Size by Service Model: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Prenatal Testing and Newborn Screening Consumption Value Market Share by Service Model in 2025
    • 1.5.3 Public Health Program
    • 1.5.4 Consumer
    • 1.5.5 Others
  • 1.6 Global Prenatal Testing and Newborn Screening Market by Application
    • 1.6.1 Overview: Global Prenatal Testing and Newborn Screening Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Public Hospitals
    • 1.6.3 Private Hospitals
    • 1.6.4 Others
  • 1.7 Global Prenatal Testing and Newborn Screening Market Size & Forecast
  • 1.8 Global Prenatal Testing and Newborn Screening Market Size and Forecast by Region
    • 1.8.1 Global Prenatal Testing and Newborn Screening Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Prenatal Testing and Newborn Screening Market Size by Region, (2021-2032)
    • 1.8.3 North America Prenatal Testing and Newborn Screening Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Prenatal Testing and Newborn Screening Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Prenatal Testing and Newborn Screening Market Size and Prospect (2021-2032)
    • 1.8.6 South America Prenatal Testing and Newborn Screening Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Prenatal Testing and Newborn Screening Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Prenatal Testing and Newborn Screening Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 Revvity
    • 2.2.1 Revvity Details
    • 2.2.2 Revvity Major Business
    • 2.2.3 Revvity Prenatal Testing and Newborn Screening Product and Solutions
    • 2.2.4 Revvity Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Revvity Recent Developments and Future Plans
  • 2.3 Quest Diagnostics
    • 2.3.1 Quest Diagnostics Details
    • 2.3.2 Quest Diagnostics Major Business
    • 2.3.3 Quest Diagnostics Prenatal Testing and Newborn Screening Product and Solutions
    • 2.3.4 Quest Diagnostics Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.4 Labcorp
    • 2.4.1 Labcorp Details
    • 2.4.2 Labcorp Major Business
    • 2.4.3 Labcorp Prenatal Testing and Newborn Screening Product and Solutions
    • 2.4.4 Labcorp Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Labcorp Recent Developments and Future Plans
  • 2.5 MedGenome
    • 2.5.1 MedGenome Details
    • 2.5.2 MedGenome Major Business
    • 2.5.3 MedGenome Prenatal Testing and Newborn Screening Product and Solutions
    • 2.5.4 MedGenome Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 MedGenome Recent Developments and Future Plans
  • 2.6 Mayo Clinic Laboratories
    • 2.6.1 Mayo Clinic Laboratories Details
    • 2.6.2 Mayo Clinic Laboratories Major Business
    • 2.6.3 Mayo Clinic Laboratories Prenatal Testing and Newborn Screening Product and Solutions
    • 2.6.4 Mayo Clinic Laboratories Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Mayo Clinic Laboratories Recent Developments and Future Plans
  • 2.7 GeneDx
    • 2.7.1 GeneDx Details
    • 2.7.2 GeneDx Major Business
    • 2.7.3 GeneDx Prenatal Testing and Newborn Screening Product and Solutions
    • 2.7.4 GeneDx Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 GeneDx Recent Developments and Future Plans
  • 2.8 PreventionGenetics
    • 2.8.1 PreventionGenetics Details
    • 2.8.2 PreventionGenetics Major Business
    • 2.8.3 PreventionGenetics Prenatal Testing and Newborn Screening Product and Solutions
    • 2.8.4 PreventionGenetics Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 PreventionGenetics Recent Developments and Future Plans
  • 2.9 SYNLAB
    • 2.9.1 SYNLAB Details
    • 2.9.2 SYNLAB Major Business
    • 2.9.3 SYNLAB Prenatal Testing and Newborn Screening Product and Solutions
    • 2.9.4 SYNLAB Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 SYNLAB Recent Developments and Future Plans
  • 2.10 Illumina
    • 2.10.1 Illumina Details
    • 2.10.2 Illumina Major Business
    • 2.10.3 Illumina Prenatal Testing and Newborn Screening Product and Solutions
    • 2.10.4 Illumina Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Illumina Recent Developments and Future Plans
  • 2.11 Cordlife
    • 2.11.1 Cordlife Details
    • 2.11.2 Cordlife Major Business
    • 2.11.3 Cordlife Prenatal Testing and Newborn Screening Product and Solutions
    • 2.11.4 Cordlife Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Cordlife Recent Developments and Future Plans
  • 2.12 KingMed Diagnostics
    • 2.12.1 KingMed Diagnostics Details
    • 2.12.2 KingMed Diagnostics Major Business
    • 2.12.3 KingMed Diagnostics Prenatal Testing and Newborn Screening Product and Solutions
    • 2.12.4 KingMed Diagnostics Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 KingMed Diagnostics Recent Developments and Future Plans
  • 2.13 BGI Genomics
    • 2.13.1 BGI Genomics Details
    • 2.13.2 BGI Genomics Major Business
    • 2.13.3 BGI Genomics Prenatal Testing and Newborn Screening Product and Solutions
    • 2.13.4 BGI Genomics Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 BGI Genomics Recent Developments and Future Plans
  • 2.14 Berry Genomics
    • 2.14.1 Berry Genomics Details
    • 2.14.2 Berry Genomics Major Business
    • 2.14.3 Berry Genomics Prenatal Testing and Newborn Screening Product and Solutions
    • 2.14.4 Berry Genomics Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Berry Genomics Recent Developments and Future Plans
  • 2.15 Annaroad
    • 2.15.1 Annaroad Details
    • 2.15.2 Annaroad Major Business
    • 2.15.3 Annaroad Prenatal Testing and Newborn Screening Product and Solutions
    • 2.15.4 Annaroad Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Annaroad Recent Developments and Future Plans
  • 2.16 Jiajian Medical Testing
    • 2.16.1 Jiajian Medical Testing Details
    • 2.16.2 Jiajian Medical Testing Major Business
    • 2.16.3 Jiajian Medical Testing Prenatal Testing and Newborn Screening Product and Solutions
    • 2.16.4 Jiajian Medical Testing Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Jiajian Medical Testing Recent Developments and Future Plans
  • 2.17 Genesky
    • 2.17.1 Genesky Details
    • 2.17.2 Genesky Major Business
    • 2.17.3 Genesky Prenatal Testing and Newborn Screening Product and Solutions
    • 2.17.4 Genesky Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Genesky Recent Developments and Future Plans
  • 2.18 Weihansi Biomedical Technology
    • 2.18.1 Weihansi Biomedical Technology Details
    • 2.18.2 Weihansi Biomedical Technology Major Business
    • 2.18.3 Weihansi Biomedical Technology Prenatal Testing and Newborn Screening Product and Solutions
    • 2.18.4 Weihansi Biomedical Technology Prenatal Testing and Newborn Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Weihansi Biomedical Technology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Prenatal Testing and Newborn Screening Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Prenatal Testing and Newborn Screening by Company Revenue
    • 3.2.2 Top 3 Prenatal Testing and Newborn Screening Players Market Share in 2025
    • 3.2.3 Top 6 Prenatal Testing and Newborn Screening Players Market Share in 2025
  • 3.3 Prenatal Testing and Newborn Screening Market: Overall Company Footprint Analysis
    • 3.3.1 Prenatal Testing and Newborn Screening Market: Region Footprint
    • 3.3.2 Prenatal Testing and Newborn Screening Market: Company Product Type Footprint
    • 3.3.3 Prenatal Testing and Newborn Screening Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Prenatal Testing and Newborn Screening Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Prenatal Testing and Newborn Screening Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Prenatal Testing and Newborn Screening Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Prenatal Testing and Newborn Screening Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Prenatal Testing and Newborn Screening Consumption Value by Type (2021-2032)
  • 6.2 North America Prenatal Testing and Newborn Screening Market Size by Application (2021-2032)
  • 6.3 North America Prenatal Testing and Newborn Screening Market Size by Country
    • 6.3.1 North America Prenatal Testing and Newborn Screening Consumption Value by Country (2021-2032)
    • 6.3.2 United States Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Prenatal Testing and Newborn Screening Consumption Value by Type (2021-2032)
  • 7.2 Europe Prenatal Testing and Newborn Screening Consumption Value by Application (2021-2032)
  • 7.3 Europe Prenatal Testing and Newborn Screening Market Size by Country
    • 7.3.1 Europe Prenatal Testing and Newborn Screening Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 7.3.3 France Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Prenatal Testing and Newborn Screening Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Prenatal Testing and Newborn Screening Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Prenatal Testing and Newborn Screening Market Size by Region
    • 8.3.1 Asia-Pacific Prenatal Testing and Newborn Screening Consumption Value by Region (2021-2032)
    • 8.3.2 China Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 8.3.5 India Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Prenatal Testing and Newborn Screening Consumption Value by Type (2021-2032)
  • 9.2 South America Prenatal Testing and Newborn Screening Consumption Value by Application (2021-2032)
  • 9.3 South America Prenatal Testing and Newborn Screening Market Size by Country
    • 9.3.1 South America Prenatal Testing and Newborn Screening Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Prenatal Testing and Newborn Screening Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Prenatal Testing and Newborn Screening Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Prenatal Testing and Newborn Screening Market Size by Country
    • 10.3.1 Middle East & Africa Prenatal Testing and Newborn Screening Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Prenatal Testing and Newborn Screening Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Prenatal Testing and Newborn Screening Market Drivers
  • 11.2 Prenatal Testing and Newborn Screening Market Restraints
  • 11.3 Prenatal Testing and Newborn Screening Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Prenatal Testing and Newborn Screening Industry Chain
  • 12.2 Prenatal Testing and Newborn Screening Upstream Analysis
  • 12.3 Prenatal Testing and Newborn Screening Midstream Analysis
  • 12.4 Prenatal Testing and Newborn Screening Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Prenatal Testing and Newborn Screening. Industry analysis & Market Report on Prenatal Testing and Newborn Screening is a syndicated market report, published as Global Prenatal Testing and Newborn Screening Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Prenatal Testing and Newborn Screening market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo